IL166306A0 - Novel synthesis of irbesartan - Google Patents

Novel synthesis of irbesartan

Info

Publication number
IL166306A0
IL166306A0 IL16630605A IL16630605A IL166306A0 IL 166306 A0 IL166306 A0 IL 166306A0 IL 16630605 A IL16630605 A IL 16630605A IL 16630605 A IL16630605 A IL 16630605A IL 166306 A0 IL166306 A0 IL 166306A0
Authority
IL
Israel
Prior art keywords
irbesartan
novel synthesis
synthesis
novel
employing
Prior art date
Application number
IL16630605A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of IL166306A0 publication Critical patent/IL166306A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Catalysts (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL16630605A 2002-07-16 2005-01-14 Novel synthesis of irbesartan IL166306A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39642402P 2002-07-16 2002-07-16
US40249002P 2002-08-09 2002-08-09
PCT/US2003/022479 WO2004007482A2 (en) 2002-07-16 2003-07-16 Novel synthesis of irbesartan

Publications (1)

Publication Number Publication Date
IL166306A0 true IL166306A0 (en) 2006-01-15

Family

ID=30118586

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16630605A IL166306A0 (en) 2002-07-16 2005-01-14 Novel synthesis of irbesartan

Country Status (11)

Country Link
US (1) US20050176794A1 (de)
EP (1) EP1546135B1 (de)
CN (1) CN1668612A (de)
AT (1) ATE340793T1 (de)
AU (1) AU2003256609A1 (de)
CA (1) CA2492779A1 (de)
DE (1) DE60308708T2 (de)
ES (1) ES2273041T3 (de)
IL (1) IL166306A0 (de)
PT (1) PT1546135E (de)
WO (1) WO2004007482A2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1759113A (zh) 2003-01-16 2006-04-12 特瓦制药工业有限公司 伊贝沙坦的新合成方法
US7038060B2 (en) * 2003-02-05 2006-05-02 Teva Pharmaceutical Industries Ltd. Synthesis of 2-butyl-3-(2′-(1-trityl-1H-tetrazol-5-yl)biphenyl-4-yl)-1,3-diazaspiro[4.4]-non-ene-4-one
GB2419592A (en) * 2004-10-26 2006-05-03 Cipla Ltd Process for the preparation of irbesartan hydrochloride
SI21965A (sl) * 2005-01-05 2006-08-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Priprava tetrazolskega derivata
WO2006097121A1 (en) * 2005-03-16 2006-09-21 Ulkar Kimya Sanayii Ve Ticaret A.S. Method for producing biphenyl-tetrazole compounds
WO2006136916A2 (en) * 2005-06-20 2006-12-28 Glenmark Pharmaceuticals Limited Substantially pure micronized particles of telmisartan and pharmaceutical compositions containing same
US7964737B2 (en) 2005-07-27 2011-06-21 Jubilant Organosys Limited Process for producing 2-(n-butyl)-3-[[2′-(tetrazol-5-yl)biphenyl-4-yl]methyl]-1,3-diazaspiro[4.4] non-1-en-4-one
EP1749828A1 (de) 2005-08-04 2007-02-07 Farmaprojects S.L. Verfahren zur Herstellung eines Angiotensin-II-Antagonisten
DE602006013261D1 (de) 2006-01-09 2010-05-12 Krka D D Irbesartan enthaltende feste Zubereitung
CA2654218C (en) 2006-04-07 2014-07-22 Lek Pharmaceuticals D.D. Process for the preparation of pure irbesartan
JP2009515834A (ja) * 2006-08-29 2009-04-16 テバ ファーマシューティカル インダストリーズ リミティド 5−フェニル−1−トリチル−1h−テトラゾールの合成のための方法
CN100413853C (zh) * 2006-09-21 2008-08-27 浙江海正药业股份有限公司 厄贝沙坦的合成中间体及其制备方法和制备药物的用途
RU2495040C1 (ru) * 2012-05-03 2013-10-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Чувашский государственный университет имени И.Н. Ульянова" Способ получения 3-амино-8-гидрокси-1,6-диоксо-2,7-диазаспиро[4.4]нон-3-ен-4-карбонитрилов
CN102875534B (zh) * 2012-09-10 2015-05-27 珠海保税区丽珠合成制药有限公司 一种厄贝沙坦的合成方法
CN105001209A (zh) * 2015-06-29 2015-10-28 千辉药业(安徽)有限责任公司 一种厄贝沙坦的合成方法
CN108218841A (zh) * 2018-03-06 2018-06-29 大桐制药(中国)有限责任公司 一种高纯度抗高血压药物依贝沙坦的合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5138069A (en) * 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
US5270317A (en) * 1990-03-20 1993-12-14 Elf Sanofi N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present
FR2725987B1 (fr) * 1994-10-19 1997-01-10 Sanofi Sa Procede pour la preparation d'un derive de tetrazole sous deux formes cristallines et nouvelle forme cristalline de ce derive
US6162922A (en) * 1998-01-30 2000-12-19 Bristol-Myers Squibb Co. Method for preparing N-substituted heterocyclic derivatives using a phase-transfer catalyst

Also Published As

Publication number Publication date
PT1546135E (pt) 2006-12-29
DE60308708T2 (de) 2007-08-23
AU2003256609A1 (en) 2004-02-02
ES2273041T3 (es) 2007-05-01
WO2004007482A2 (en) 2004-01-22
DE60308708D1 (de) 2006-11-09
US20050176794A1 (en) 2005-08-11
AU2003256609A8 (en) 2004-02-02
CN1668612A (zh) 2005-09-14
EP1546135B1 (de) 2006-09-27
EP1546135A2 (de) 2005-06-29
WO2004007482A3 (en) 2004-05-27
CA2492779A1 (en) 2004-01-22
ATE340793T1 (de) 2006-10-15

Similar Documents

Publication Publication Date Title
AU2003256609A8 (en) Novel synthesis of irbesartan
AU2003254465A1 (en) Cvd synthesis of carbon nanotubes
DE60239428D1 (de)
MY129188A (en) Metalloproteinase inhibitors
MY136728A (en) Preparation of titania and cobalt aluminate catalyst supports and their use in fischer-tropsch synthesis
IL133249A0 (en) Ortho-metalation process for the synthesis of 2-substituted-1-(tetrazol-5-yl) benzenes
AU2003253203A1 (en) Phase locked loop
MY143266A (en) New process for synthesizing (7-methoxy-3,4-dihydro-1-naphthalenyl)acetonitrile and its application in the synthesis of agomelatine
MY136938A (en) New process for the synthesis of perindopril and its pharmaceutically acceptable salts
ZA200108480B (en) Novel synthesis of piperazine ring.
AU2002316593A1 (en) Solid phase synthesis of arylretinamides
GB0108234D0 (en) Process for producing trunkamide A compounds
AU2003276330A1 (en) Novel compounds comprising a thiocarbonyl-sulfanyl group, which can be used for the radical synthesis of alpha-perfluoroalkylamines
AU2003218176A1 (en) Asymetric synthesis of amino-pyrrolidinones
MY136638A (en) New process for the synthesis of perindopril and its pharmaceutically acceptable salts
MXPA04004526A (es) N-metil-homocisteinas, su uso y metodo para su produccion.
NO20044927L (no) Fremgangsmate for syntese av beta-L-5-fluor-2`,3`-dideoksy-2`,3`-dihydrocutidin (beta-L-FD4C)
AU2003261853A1 (en) Process for preparing azo compound
MY136989A (en) New process for the synthesis of perindopril and pharmaceutically acceptable salts thereof
AU2003269732A1 (en) Catalyst for the synthesis of ammonia
GEP20094740B (en) Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
AU2003217354A1 (en) Synthesis of sulfamidates
AU2003218407A1 (en) Synthesis of 2,6-dicarbonylpyridines
AU2003251431A1 (en) Synthesis of discodermolide
AU2001273968A1 (en) Production of 2-ethyl-3-methyl-1,4-diazine